Octreotide Acetate Injection, Solution
Product Images NDC 68083-515

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Octreotide Acetate (NDC 68083-515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Gland Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Octreotide-spl-1000-mcg-carton (Octreotide Spl 1000 Mcg Carton)

Packaging label for Octreotide Acetate Injection 1,000 mcg/5 mL (200 mcg/mL) multiple-dose vial. The label indicates the product is for subcutaneous or intravenous injection and includes storage instructions to refrigerate at 2°C to 8°C (36°F to 46°F), protect from light, and discard within 14 days after initial use. Manufactured by Gland Pharma Limited in Hyderabad, India. Includes a barcode and NDC 68083-515-01.*

FDA Label Image

Octreotide-spl-1000-mcg-vial (Octreotide Spl 1000 Mcg Vial)

Label for Octreotide Acetate Injection 1,000 mcg/5 mL (200 mcg/mL) solution for subcutaneous or intravenous injection. The label indicates a 5 mL multiple-dose vial manufactured by Gland Pharma Limited, Hyderabad, India. Storage instructions advise refrigeration at 2°C to 8°C (36°F to 46°F) and protection from light. Rx only.*

FDA Label Image

Octreotide-spl-5000-mcg-carton (Octreotide Spl 5000 Mcg Carton)

Packaging label for Octreotide Acetate Injection 5,000 mcg/5 mL (1,000 mcg/mL) multiple-dose vial. The injectable solution is for subcutaneous or intravenous injection. Label includes storage instructions to refrigerate at 2°C to 8°C (36°F to 46°F) and discard within 14 days after initial use. Manufactured by Gland Pharma Limited, Hyderabad, India. NDC 68083-516-01.*

FDA Label Image

Octreotide-spl-5000-mcg-vial (Octreotide Spl 5000 Mcg Vial)

Label for Octreotide Acetate Injection 1000 mcg/mL (5,000 mcg/5 mL) in a multiple-dose vial. The label indicates the drug is for subcutaneous or intravenous injection, manufactured by Gland Pharma Limited in Hyderabad, India. Storage instructions specify refrigeration at 2°C to 8°C and protection from light. The label includes barcode and lot/expiration placeholders.*

FDA Label Image

Octreotide-spl-structure (Octreotide Spl Structure)

Chemical structure diagram showing the peptide sequence for Octreotide Acetate. The structure depicts amino acid residues and a variable position marked as x CH3COOH, representing a component of the molecule.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.